Yuzu Health

Yuzu Health

Private
New York City, New YorkEnterprise Softwarehttps://yuzu.health

Last Round

Series A

Apr 6, 2026

Total Funding Raised

$40M

Momentum Score

50 /100

Company Overview

Yuzu Health is a healthcare technology company that provides a third-party administrator (TPA) platform for businesses to create and manage their own health insurance plans.

Sector

Enterprise Software

Verticals

InsurTech, Vertical SaaS, HR, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

Third-Party AdministratorTPAself-funded health planshealth plan administrationmodern TPAbenefits administrationTPA softwarehealth plan infrastructureself-insured health plansautomated claims processingAI claims processingwhite-label TPA platformhealth benefits for SMBsReference Based PricingPMPM billingin-house claims engine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yuzu Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Yuzu Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 6, 2026
SeedOct 31, 2023

Key People

Founding team and executive leadership

Max Kauderer

Co-Founder CEO

Founding Team

Yuzu Health Investors

Notable investors and investment history

InvestorRounds
CoalitionSeed
NeoSeed, Series A
Timeless VenturesSeries A
Browder CapitalSeed
Timeless VenturesSeries A
Chemistry VCSeries A
Anthology FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Alex Tran from General Catalyst joins the board.

  • Apr 6, 2026

    $35M round completed.

Yuzu Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yuzu Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yuzu Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range51
Year Founded2022
Last FundingApr 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.